However, in a subset of RCC patients with substantial PTEN expression, PTEN is seen to enhance HIF-2α activity, but not the protein level, by negative regulation of YY1, the HIF-2α co-repressor, and the downstream target genes MT1-MMP, in VHL−/− RCC cells [71]. The gene discussed is PTEN; the disease is renal cell carcinoma.